Intraventricular hemorrhage outcome

• Establishment and evaluation of a novel rat model of the fourth ventricle hemorrhage
• Mitral Annular Calcification, a Not So Marginal and Relatively Benign Finding as Many of Us Think: A Review
• Confidential Audit of Perinatal Mortality in the Republic of Kazakhstan: A Pilot Study
• 'Father of neonatal neurology': the life of Joseph J. Volpe
• Early treatment versus expectant management of hemodynamically significant patent ductus arteriosus for preterm infants
• Active Cerebrospinal Fluid Exchange vs External Ventricular Drainage in the Neurocritical Care Unit: An International, Retrospective Cohort Study
• Risk factors for the development of hydrocephalus in traumatic brain injury: a systematic review and meta-analysis
• Pharmacological interventions for the prevention of pain during endotracheal suctioning in ventilated neonates

It is the most severe form of stroke.

The presence of intraventricular hemorrhage portends a high risk of developing Posthemorrhagic hydrocephalus and decreased survival ¹⁾.

The significance of delayed intraventricular haemorrhage (dIVH) is less well defined.

One hundred thirty-nine (51.3 %) patients with intraventricular hemorrhage developed ventricular dilatation, but only 47 patients (17.34 %) needed shunting. In seven cases, temporary neurosurgical procedures were performed, but in all of them, this was followed by ventriculoperitoneal shunt implantation. The infection rate was 4.25 %, and shunt obstruction rate was 4.25 %. More than 80 % of patients were classified as good or excellent functional state. Mean follow-up period was 38.75 months (SD, 27.09; range, 1-102 months).